Rbo & Co Boosted Regency Centers (REG) Position By $1.89 Million; 2 Bullish Analysts Covering Oxford BioMedica PLC (LON:OXB)

February 20, 2018 - By Nellie Frank

Among 4 analysts covering Oxford BioMedica PLC (LON:OXB), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 50% are positive. Oxford BioMedica PLC had 22 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of Oxford BioMedica PLC (LON:OXB) has “Buy” rating given on Thursday, July 13 by Jefferies. The rating was maintained by Jefferies on Friday, March 17 with “Buy”. Peel Hunt maintained the shares of OXB in report on Tuesday, October 31 with “Buy” rating. Shore Capital maintained Oxford BioMedica PLC (LON:OXB) on Thursday, July 13 with “Not Rated” rating. The firm has “Hold” rating by N+1 Singer given on Thursday, July 6. The company was maintained on Monday, March 7 by N+1 Singer. Jefferies maintained the stock with “Buy” rating in Thursday, August 31 report. The stock of Oxford BioMedica PLC (LON:OXB) earned “Buy” rating by Peel Hunt on Thursday, February 15. The firm earned “Buy” rating on Thursday, August 27 by N+1 Singer. The company was maintained on Friday, January 29 by N+1 Singer. See Oxford BioMedica PLC (LON:OXB) latest ratings:

15/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 13.00 New Target: GBX 13.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 13.00 New Target: GBX 13.00 Maintain
08/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 13.00 New Target: GBX 13.00 Maintain
31/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 13.00 New Target: GBX 13.00 Maintain
19/09/2017 Broker: Peel Hunt Rating: Buy New Target: GBX 13.00 Initiates Starts
31/08/2017 Broker: N+1 Singer Rating: Hold Old Target: GBX 8.70 New Target: GBX 10.20 Maintain
31/08/2017 Broker: Jefferies Rating: Buy Old Target: GBX 13.00 New Target: GBX 13.00 Maintain

Rbo & Co Llc increased Regency Centers (REG) stake by 24.12% reported in 2017Q3 SEC filing. Rbo & Co Llc acquired 30,534 shares as Regency Centers (REG)’s stock declined 13.08%. The Rbo & Co Llc holds 157,129 shares with $9.75 million value, up from 126,595 last quarter. Regency Centers now has $10.09 billion valuation. The stock increased 1.22% or $0.71 during the last trading session, reaching $58.75. About 895,129 shares traded. Regency Centers Corporation (NYSE:REG) has declined 19.56% since February 20, 2017 and is downtrending. It has underperformed by 36.26% the S&P500.

Among 20 analysts covering Regency Centers Corporation (NYSE:REG), 9 have Buy rating, 0 Sell and 11 Hold. Therefore 45% are positive. Regency Centers Corporation had 60 analyst reports since July 21, 2015 according to SRatingsIntel. Evercore maintained the shares of REG in report on Tuesday, September 8 with “Hold” rating. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, November 1. The firm earned “Neutral” rating on Thursday, August 25 by BTIG Research. The stock of Regency Centers Corporation (NYSE:REG) earned “Outperform” rating by RBC Capital Markets on Thursday, November 5. As per Friday, September 15, the company rating was downgraded by Jefferies. The rating was upgraded by BTIG Research to “Buy” on Monday, January 29. The rating was maintained by Citigroup with “Neutral” on Friday, August 12. The firm earned “Equal-Weight” rating on Friday, August 14 by Barclays Capital. The firm has “Buy” rating by Argus Research given on Wednesday, November 25. The stock of Regency Centers Corporation (NYSE:REG) has “Market Perform” rating given on Monday, January 9 by Raymond James.

Since August 23, 2017, it had 0 buys, and 10 insider sales for $116.82 million activity. $174,725 worth of stock was sold by ROTH ALAN TODD on Friday, December 15. 17,600 shares valued at $1.13 million were sold by KATZMAN CHAIM on Thursday, January 18. $511,129 worth of Regency Centers Corporation (NYSE:REG) shares were sold by FIALA MARY LOU. The insider THOMPSON JAMES D. sold $1.03M.

Investors sentiment increased to 1.15 in Q3 2017. Its up 0.06, from 1.09 in 2017Q2. It improved, as 23 investors sold REG shares while 107 reduced holdings. 33 funds opened positions while 116 raised stakes. 154.04 million shares or 1.05% more from 152.45 million shares in 2017Q2 were reported. Texas-based Employees Retirement Of Texas has invested 0.11% in Regency Centers Corporation (NYSE:REG). 1832 Asset Mngmt Lp holds 0.01% or 50,365 shares in its portfolio. Sentry Invs accumulated 22,400 shares or 0.01% of the stock. Wolverine Asset Limited Liability Com, Illinois-based fund reported 4,899 shares. Ameritas Partners Incorporated reported 3,500 shares. Teachers Insurance Annuity Association Of America invested 0.25% in Regency Centers Corporation (NYSE:REG). California Pub Employees Retirement Sys owns 0.03% invested in Regency Centers Corporation (NYSE:REG) for 288,491 shares. Wells Fargo And Mn has 0.03% invested in Regency Centers Corporation (NYSE:REG). Moreover, Financial Svcs has 0% invested in Regency Centers Corporation (NYSE:REG) for 20 shares. New York State Teachers Retirement Systems owns 201,289 shares. M&T National Bank holds 11,329 shares or 0% of its portfolio. Amp Cap reported 134,101 shares stake. Moreover, Gemmer Asset Mngmt Llc has 0% invested in Regency Centers Corporation (NYSE:REG) for 46 shares. Green Street Investors Lc, California-based fund reported 72,800 shares. Pnc Fincl Svcs Group holds 3,198 shares or 0% of its portfolio.

Oxford BioMedica plc, a biopharmaceutical company, researches, develops, and produces gene and cell therapy products for the treatment of ocular, neurodegenerative, and cancer diseases in Europe and rest of world. The company has market cap of 369.37 million GBP. The firm operates through Partnering and R&D divisions. It currently has negative earnings. The Company’s LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple therapeutic genes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Nellie Frank

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: